# Financial toxicity: screening, the cost conversation and referral for money, benefits and work support

Source: https://onco.cc/protocols/financial-toxicity-screening-and-support/  
OnCo record `financial-toxicity-screening-and-support` (Protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Cancer costs money in every health system: bills and insurance payments in some countries, and lost wages and travel costs even where treatment is free. Your team should ask about money early, because help exists and is often missed: a social worker, financial counsellor or benefits adviser can check what you can claim. Money trouble can lead people to skip medicines, so it is part of your care.

## Summary

ESMO's 2024 expert consensus (19 experts, 11 countries, 25 statements) is the only society statement found that covers screening and management across health systems. It asks for a preliminary assessment of financial impact at diagnosis or before treatment (LoE: V), suggests a sequential strategy of a single screening question followed by a longer validated questionnaire such as COST (11 scored items, 0 to 44, lower is worse), and calls it ethically and medically reasonable to offer financial counselling from a dedicated professional such as a social worker after a positive screen (LoE: III). ASCO's 2009 guidance statement recognised discussion of the cost of care as a component of high-quality care. Most of the evidence is weak: ESMO's practice statements are graded III to V.

What the money problem is differs by system. In the United States it is led by out-of-pocket medical costs: the NCI summary reports cancer survivors 2.7 times more likely to file for bankruptcy, and that fewer than one third of patients have had a cost discussion. In publicly funded systems it is led by lost income and non-medical costs: a systematic review of 32 studies found lost income of 17.6 to 67.3 per cent and out-of-pocket costs of US$17 to US$506 a month, and a UK scoping review found no study using a validated measure. The response differs to match: financial navigation in the United States, benefits and welfare rights advice in the United Kingdom.

Whether these services work is less clear than whether the problem exists. In the CAFE randomised trial (371 people newly diagnosed, two US health systems) proactive financial navigation did not improve financial hardship or quality of life at 12 months against enhanced usual care; a meta-analysis found no significant pooled change in COST score but an effect in people with the worst scores at entry. This page describes what guidelines and studies say; a person's own team, and the benefits rules of their own country, come first.

## Fields

- Kind: Protocol
- Last checked: 2026-11-17
- Also known as: financial toxicity screening; financial hardship in cancer; cost of cancer to patients; cost of care conversation; financial navigation; financial counselling; benefits advice; welfare rights advice; COST questionnaire; money worries during cancer treatment
- Tags: protocol; supportive-care; financial-toxicity; psychosocial

## Connected records

- protocols: [Consent and education before anticancer treatment](https://onco.cc/protocols/consent-and-education-before-anticancer-treatment/), [Distress screening with the distress thermometer, and referral by need](https://onco.cc/protocols/distress-screening-and-referral/), [End of treatment: treatment summary, survivorship care plan and handover to primary care](https://onco.cc/protocols/survivorship-care-plan-and-treatment-summary/)
- collections: [Macmillan Support Line](https://onco.cc/collections/macmillan-support-line/)
- ideas: [Financial navigation offered to the people who screen worst for money trouble, rather than to everyone](https://onco.cc/ideas/idea-upgrade-financial-navigation-targeted-by-screening-score/), [Screen every patient for financial hardship at diagnosis and connect them to help](https://onco.cc/ideas/idea-acc-financial-toxicity-screening-at-diagnosis/), [Vocational rehabilitation integrated into cancer care so survivors can return to work](https://onco.cc/ideas/idea-acc-return-to-work-rehabilitation/)
- technologies: [Employment rights with cancer in the United Kingdom](https://onco.cc/technologies/rejuv-life-employment-rights-uk/), [Employment rights with cancer in the United States](https://onco.cc/technologies/rejuv-life-employment-rights-us/), [Financial toxicity and financial navigation](https://onco.cc/technologies/financial-navigation/), [Going back to work after cancer: the rates, and the programmes that change them](https://onco.cc/technologies/rejuv-life-return-to-work/)
- fronts: [Supportive Care & Survivorship](https://onco.cc/fronts/supportive-care/)
- institutions: [American Society of Clinical Oncology (ASCO)](https://onco.cc/institutions/asco/), [European Society for Medical Oncology (ESMO)](https://onco.cc/institutions/esmo/), [Macmillan Cancer Support](https://onco.cc/institutions/macmillan-cancer-support/)
- terms: [Financial toxicity](https://onco.cc/terms/financial-toxicity/), [Patient navigation in cancer care](https://onco.cc/terms/patient-navigation/), [Quality of life](https://onco.cc/terms/quality-of-life/)

---
JSON: https://onco.cc/api/v1/entities/financial-toxicity-screening-and-support.json